Search for Clinical Trial Results

Sponsored By

Leukemia, T-Cell - 50 Studies Found

Status Study
Completed Study Name: Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia
Condition: Leukemia, T-Cell
Date: 2004-11-03
Interventions: Drug: forodesine hydrochloride (BCX-1777)
Active, not recruiting Study Name: KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)
Condition: Adult T-cell Leukemia-Lymphoma
Date: 2012-06-19
Interventions:
  • Biological: KW-0761 1.0 mg/kg

Active, not recruiting Study Name: Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia
Condition: Adult T-Cell Leukemia (ATL)
Date: 2009-06-17
Interventions:
  • Drug: LMB-2 Begin with 30 mcg/
Completed Study Name: Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac
Condition:
  • Leukemia, T-Cell
  • Lymphoma, T-Cell, Cutaneous

Date: 1999-11-03
Interventions: Drug: Yttrium-90 radiolabeled anti-Tac antibody
Completed Study Name: Phase II Study of KW-0761 in Subjects With CCR4-positive Adult T-cell Leukemia-lymphoma
Condition: Adult T-cell Leukemia-lymphoma
Date: 2009-06-09
Interventions: Biological: KW-0761 KW-0761 is administered weekly for 8 weeks as an intravenous infusion of 2 hours at
Completed Study Name: Lenalidomide in HTLV-1 Adult T-Cell Leukemia
Condition: Adult T Cell Leukemia/Lymphoma
Date: 2011-01-10
Interventions: Drug: Lenalidomide 25mg or 10mg (based on creatinine clearance) once daily for days 1-21 of a 28 day cyc
Active, not recruiting Study Name: A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma
Condition: Adult T-Cell Leukemia-Lymphoma
Date: 2012-11-07
Interventions: Drug: Lenalidomide 25 mg of Lenalidomide administered orally once daily
Completed Study Name: Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma
Condition: Acute T-Cell Leukemia-Lymphoma
Date: 2003-05-20
Interventions: Biological: Alemtuzumab Infusion of Campath-1H 3 mg on day # 1, 10 mg on day #2, and 30 mg day # 3 follo
Recruiting Study Name: Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma
Condition:
  • Adult T-cell Leukemia-Lymphoma
  • ATLL

Date: 2016-04-10
Interventions:
  • Drug: Belinostat Belinostat wi
Recruiting Study Name: Ruxolitinib for Adult T-Cell Leukemia
Condition: